Novel combi treatment to boost efficacy of antibody therapies
Antibody-mediated therapies have evolved as a mainstay of targeted anti-cancer therapy but also of auto-immune and other diseases. However, antibody drug resistance during treatment and thus poor performance are one of the major obstacles for efficient therapy. Scientists of the University of Göttingen have now developed a new treatment regime of a combined drug administration, improving the efficacy of the antibody response.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
Media Contact
All latest news from the category: Technology Offerings
Newest articles
Silicon Carbide Innovation Alliance to drive industrial-scale semiconductor work
Known for its ability to withstand extreme environments and high voltages, silicon carbide (SiC) is a semiconducting material made up of silicon and carbon atoms arranged into crystals that is…
New SPECT/CT technique shows impressive biomarker identification
…offers increased access for prostate cancer patients. A novel SPECT/CT acquisition method can accurately detect radiopharmaceutical biodistribution in a convenient manner for prostate cancer patients, opening the door for more…
How 3D printers can give robots a soft touch
Soft skin coverings and touch sensors have emerged as a promising feature for robots that are both safer and more intuitive for human interaction, but they are expensive and difficult…
